Pacur Pharmaceuticals Private Limited
About Pacur Pharmaceuticals Private Limited
Data last updated:
Pacur Pharmaceuticals Private Limited is a private limited company based in Chhindwara, Madhya Pradesh, India. It operates in the manufacturing sector. It was incorporated on 10 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U36999MP2018PTC046512. Its GSTIN is 23AAKCP1160H1ZO (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Krishna Gohite (Managing Director) and Pannalal Shesarao Gohite.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Shri Pannalal Sheshrao Gohite Pandhri Ward Pandhurna, Chhindwara, Madhya Pradesh, India – 480334.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.66 Lakh, a growth of 44% compared to the previous year. For the same year it recorded a net profit of ₹75,810 (net margin 4.3%) and EBITDA of ₹1.02 Lakh (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 44% over three years and 167% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Shri Pannalal Sheshrao Gohite Pandhri Ward Pandhurna, Chhindwara, Madhya Pradesh, India – 480334
- IndustryManufacturing, Manufacturing, Other
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Pacur Pharmaceuticals Private Limited
The main business activity of Pacur Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Pacur Pharmaceuticals Private Limited FY 2025 filings available
Pacur Pharmaceuticals Private Limited reported revenue of ₹17.66 Lakh (up 44% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Pacur Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 167% over five years, including 44% growth in the latest year. EBITDA rose 162% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pacur Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.02 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹75,810 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pacur Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pacur Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Pacur Pharmaceuticals Private Limited
Pacur Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kmcure Pharmaceuticals Private Limited | ₹17.72 Lakh (FY 2025) | •••• | •••• | -32.0% | •••• | Patna, Bihar, India |
| Fencare Pharmaceuticals Private Limited | ₹17.71 Lakh (FY 2025) | •••• | •••• | -74.0% | •••• | Bangalore, Karnataka, India |
| Welcode Pharmaceuticals Private Limited | ₹17.71 Lakh (FY 2021) | •••• | •••• | 6.0% | •••• | Thane, Maharashtra, India |
| Vipanil Pharmaceuticals Private Limited | ₹17.68 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | Delhi, India |
| Mevon Pharmaceuticals Private Limited | ₹17.66 Lakh (FY 2024) | •••• | •••• | 57.0% | •••• | Patna, Bihar, India |
| Pacur Pharmaceuticals Private Limited this company | ₹17.66 Lakh (FY 2024) | •••• | •••• | 44.0% | •••• | Chhindwara, Madhya Pradesh, India |
| Carmaluxe Pharmaceuticals Private Limited | ₹17.65 Lakh (FY 2025) | •••• | •••• | -37.0% | •••• | Pune, Maharashtra, India |
| Ranek Pharmaceuticals Private Limited | ₹17.65 Lakh (FY 2024) | •••• | •••• | 169.0% | •••• | Guwahati, Assam, India |
| Baxy Pharmaceuticals Private Limited | ₹17.65 Lakh (FY 2025) | •••• | •••• | -4.0% | •••• | Karan Nagar, Jammu and Kashmir, India |
| Viams Pharmaceuticals Private Limited | ₹17.63 Lakh (FY 2025) | •••• | •••• | -8.0% | •••• | Delhi, India |
| Mayuvachi Pharmaceuticals Private Limited | ₹17.6 Lakh (FY 2025) | •••• | •••• | 24.0% | •••• | Gwalior, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Pacur Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Pacur Pharmaceuticals Private Limited
Pacur Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishna Gohite | Managing Director | 10 Sep 2018 | 8 Years 1 Months | Current |
| Pannalal Shesarao Gohite | Director | 10 Sep 2018 | 8 Years 1 Months | Current |
Ownership and Shareholding of Pacur Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pacur Pharmaceuticals Private Limited
Pacur Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Pacur Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Pacur Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pacur Pharmaceuticals Private Limited
Pacur Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Krishna Gohite was appointed as Managing Director on 10 Sep 2018.
Credit Ratings, Litigation & Regulatory Alerts for Pacur Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pacur Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pacur Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pacur Pharmaceuticals Private Limited
Pacur Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAKCP1160H1ZO | Madhya Pradesh | Active | 29 Dec 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pacur Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pacur Pharmaceuticals Private Limited
Pacur Pharmaceuticals is an active private limited company based in Chhindwara, Madhya Pradesh, India. The company works in the manufacturing industry. It was incorporated on 10 September 2018 (8+ years old) and is registered under CIN U36999MP2018PTC046512.
Pacur Pharmaceuticals reported revenue of ₹17.66 Lakh for FY 2024 (up 44% YoY).
Pacur Pharmaceuticals has 2 current directors:
- Krishna Gohite - Managing Director
- Pannalal Shesarao Gohite - Director
Pacur Pharmaceuticals reported a net profit of ₹75,810 (net margin 4.3%) and EBITDA of ₹1.02 Lakh (EBITDA margin 5.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pacur Pharmaceuticals is 44% over three years and 167% over five years. In the latest year (FY 2024) revenue rose 44%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Pacur Pharmaceuticals is 23AAKCP1160H1ZO, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Pacur Pharmaceuticals is U36999MP2018PTC046512. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pacur Pharmaceuticals was incorporated on 10 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Pacur Pharmaceuticals by revenue are Kmcure Pharmaceuticals Private Limited, Fencare Pharmaceuticals Private Limited, Welcode Pharmaceuticals Private Limited, Vipanil Pharmaceuticals Private Limited, Mevon Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Krishna Gohite was appointed as Managing Director on 10 Sep 2018. Pannalal Shesarao Gohite was appointed as Director on 10 Sep 2018.
The registered office of Pacur Pharmaceuticals is at CO Shri Pannalal Sheshrao Gohite Pandhri Ward Pandhurna, Chhindwara, Madhya Pradesh, India – 480334.